Washington Trust Advisors’s Zimmer Biomet ZBH Stock Holding History

Washington Trust Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14	Closed	-$1.27K	–	774
2026 Q1	$1.27K	Sell	14 -214	-94%	-$19.6K	﹤0.01%	623
2025 Q4	$20.5K	Hold	228	–	–	﹤0.01%	436
2025 Q3	$22.5K	Hold	228	–	–	﹤0.01%	429
2025 Q2	$20.8K	Sell	228 -34	-13%	-$3.29K	﹤0.01%	397
2025 Q1	$29.7K	Buy	+262	New	+$28K	﹤0.01%	363
2023 Q2	–	Sell	-41	Closed	-$5.3K	–	778
2023 Q1	$5.3K	Hold	41	–	–	﹤0.01%	595
2022 Q4	$5.23K	Sell	41 -188	-82%	-$21.8K	﹤0.01%	598
2022 Q3	$24K	Buy	229 +2	+0.9%	+$219	﹤0.01%	492
2022 Q2	$24K	Hold	227	–	–	﹤0.01%	517
2022 Q1	$29K	Sell	227 -232	-51%	-$28K	﹤0.01%	534
2021 Q4	$57K	Buy	+459	New	+$60.1K	﹤0.01%	450

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Washington Trust Advisors's ZBH Position: Q2 2026 in Review

Washington Trust Advisors sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 14 shares — an estimated $1.27K sold.

Washington Trust Advisors first reported a position in ZBH in Q4 2021 and held it in 11 quarters. The position peaked at $57K in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Washington Trust Advisors reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Washington Trust Advisors sold 14 Zimmer Biomet shares in Q2 2026, an estimated $1.27K.
Washington Trust Advisors first reported a position in Zimmer Biomet in Q4 2021 and held it in 11 quarters.
Washington Trust Advisors's Zimmer Biomet position peaked at $57K in Q4 2021.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.